16th March – 18th March
2019 The New Orleans Ernest N. Morial Convention Center, the USA
ACC (The American College of Cardiology) was founded in 1949, aimed to improve quality of life of patients through continuous improvement of service quality. By improving the quality of cardiovascular care and providing education and related services to cardiologists all over the world over 60 years. ACC has become a well-known world leader in cardiology. The annual exhibition hosted by the ACC is an important annual meeting in the cardiovascular field
RainMed is honored to participate in ACC19 and present our CAFFRTMFlashAngioTM System and hosted over 60 cardiologists around the world. The innovative pressure based FFR system has catch the eye balls of many cardiologolists and experts. They are quite excited to see something really like this and bring the change to the long used FFR physiology. This innovative technique was believed to have high potential and capability to bring up the use rate of FFR , which shows its benefits to patients and the healthcare system through many studies.
Thank you all for visiting RainMed Medical at ACC19. We appreciate your visit and interest in our booth. It was really our pleasure to see you and discuss about our new technology or business opportunities with you at the exhibition.
Check out these highlights!
Thank you for your attendance, it will be our pleasure to meet you at EuroPCR in May.
About CAFFRTM FlashAngioTM System
The main purpose of our products is to further reduce the occurrence of MACE (Major Adverse Cardiac Events). Compared with conventional FFR assessment methods, CAFFRTM FlashAngioTM System has many significant advantages. No adenosine, no guidewire required, thus no wedging or drifting and all the hassle. Dedicated designed CFD algorithm offers resolution to Navier-Stokes formula in 10 seconds, to make the operation process more efficient. Innovative unique multi-functionality with proprietary sensor monitoring real-time aortic pressure in all stages of cardiac cycle and assessing more physiology parameters simultaneously to reach 96% accuracy result within 3 minutes.
RainMed Medical Technology Co., Ltd. is a high-tech enterprise specializing in the development of accurate diagnosis and treatment of cardiovascular diseases. The company has independent development capacity for medical devices with clinically approved quality and has obtained more than 20 patents. The product has been clinically recognized and approved by a number of medical facilities.
For further information, please contact:
RainMed International Department：InternationalBD@rainmed.com